CVS Health Corporation’s Stock Price Soars to $44.89, Marking a Robust 2.16% Uptick

CVS Health Corporation (CVS)

44.89 USD +0.95 (+2.16%) Volume: 11.59M

CVS Health Corporation’s stock price sees a positive surge, trading at 44.89 USD with a session growth of +2.16% on a volume of 11.59M shares, despite a year-to-date decline of -43.55%.

Latest developments on CVS Health Corporation

Today, CVS Health Corp stock price movements were influenced by unusual options activity on December 30th. Investors are speculating on whether CVS Health Corporation (CVS) is the best pharma dividend stock to buy in 2024, making it an attractive option in the healthcare sector. As one of the cheap healthcare stocks to buy heading into 2025, CVS Health Corp is garnering attention from investors looking for potential growth opportunities in the coming year.

CVS Health Corporation on Smartkarma

Analysts at Baptista Research on Smartkarma have been closely following Cvs Health Corp‘s performance and strategic direction. In their research report titled “CVS Health Corporation: Expansion & Optimization of Health Services As A Critical Factor Driving Growth! – Major Drivers,” they highlight the company’s revenue reaching approximately $95.4 billion, showing a 6% increase from the previous year. However, challenges are noted in the adjusted earnings per share (EPS) of $1.09, particularly within the Health Care Benefits (HCB) segment.

Another report by Baptista Research on Smartkarma focuses on Cvs Health Corp‘s strategic leverage in Pharmacy Benefit Management (PBM) and Insurance Operations. Titled “CVS Health Corporation: Strategic Leverage in Pharmacy Benefit Management (PBM) and Insurance Operations! – Major Drivers,” the analysts note mixed financial results in the second quarter of 2024. The company delivered an adjusted earnings per share of $1.83 and saw revenues exceeding $91 billion, with a strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

A look at CVS Health Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, CVS Health Corp seems to have a positive long-term outlook. The company scored high in value and dividend, indicating strong financial health and potential for returns to shareholders. However, its growth and resilience scores were slightly lower, suggesting some room for improvement in these areas. With a lower momentum score, CVS Health Corp may face challenges in maintaining market momentum in the near future.

CVS Health Corporation is an integrated pharmacy health care provider with a strong focus on pharmacy benefit management services and retail pharmacy operations. The company also offers disease management programs and operates retail clinics. Despite scoring high in value and dividend, CVS Health Corp may need to work on improving its growth and resilience factors to ensure long-term success in the competitive healthcare industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma